New cancer drug enters human testing for multiple advanced tumors
NCT ID NCT06774963
Summary
This is the first human study of LNCB74, a new targeted cancer drug designed to deliver chemotherapy directly to cancer cells. Researchers will test different doses in 145 adults with advanced solid tumors (including ovarian, breast, lung, and other cancers) to find the safest and most effective amount. The main goals are to check for side effects and determine the best dose for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic Taussig Cancer Institute
RECRUITINGCleveland, Ohio, 44195, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hoag Family Cancer Institute
RECRUITINGNewport Beach, California, 92663, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Inova Schar Cancer Institute
RECRUITINGFalls Church, Virginia, 22031, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Intermountain/LDS Hospital Ph 1 Research Program
RECRUITINGSalt Lake City, Utah, 84143, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
John Theurer Cancer Ctr at Hackensack Univ. Med Ctr.
NOT_YET_RECRUITINGHackensack, New Jersey, 07601, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
MD Anderson
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
NEXT Oncology
COMPLETEDSan Antonio, Texas, 78229, United States
-
Roswell Park Comprehensive Cancer Center
RECRUITINGBuffalo, New York, 14203, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sidney Kimmel Comprehensive Center at Jefferson
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St. Elizabeth Healthcare
RECRUITINGEdgewood, Kentucky, 41017, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UPMC
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UT Health San Antonio - MD Anderson Cancer Center
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Washington University, Siteman Cancer Center
RECRUITINGSt Louis, Missouri, 63108, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.